Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events rsv risk healthy preterm babies how well do we understand it
… who were receiving hemodialysis. We wanted to understand how the unique healthcare utilization patterns of patients … serious. Some very clear patterns emerged. Some milder events had very clear spikes in incidence every 2 to 3 days, … show clear cycles, presumably because hospitalizations do not occur with predictable frequency like dialysis …
… of the model structure and the quality of the data, but it must also be flexible, transparent, and user-friendly, which is why we staff all projects with senior researchers and modelers … and interactive models Whether you need a model to help understand unmet needs, guide strategic planning, conduct …
… What Do Patients with Parkinson’s Disease Value Most In … on-demand treatment therapies to relieve these episodes. It was not understood, however, which aspects of the … to full "ON" (the time it would take to relieve symptoms) How long symptom relief would last Cost Overall, respondents …
… webinar where you’ll learn: Health Technology Assessment: How do HTA bodies define rare or ultra-orphan diseases? How do … challenges to developing cost-effectiveness models? How do we overcome these HTA economic modelling challenges? …
… is considered in the development of new therapies—we are passionate about what we do. Our scientists actively participate in industry special …
… How Much Does TLV Value Rarity? A Review of Reimbursement … life-year gained due to rarity. Given that, we sought to determine if the rarity of the conditions … the results. Lanne G, Kinderås M, Ling C, Brodtkorb TH. How much does TLV value rarity? A review of reimbursement …
… More than ever, health economic information affects how patients, providers, payers , and regulators make decisions, and we understand your need for credible, reliable, and high-quality …
… Causal Inference Using Real-World Data: How Pharmacoepidemiology Studies Can Benefit From the Target … clinical trials and robust information on rare adverse events was lacking. As the availability of real-world data … decisions. Related Services Pharmacoepidemiology and Risk Management Staff Members Julia Vila Guilera Xabier …
… of therapies that address high unmet medical needs as well as the use of comparative clinical trials, and there are other factors as well. How is the pharmaceutical industry responding to these new … Act clock starts with the first approval. They might also do so because of the additional workload and the …
… of therapies that address high unmet medical needs as well as the use of comparative clinical trials, among other factors. How is the Pharmaceutical Industry Responding to These New … IRA clock starts with the first approval. They might also do so because of the additional workload and the …